Average NPY scores were lower in prostate cancers that later recurred (geometric mean 17.6, 95% CI: 9.5-32.5) compared to those that did not (38.7, CI: 23.2-64.4; <i>p</i>: 0.044, d: 0.773). Here, NPY is linked to prostate cancer.